Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000646114 | SCV000767871 | likely benign | Epilepsy, childhood absence, susceptibility to, 1; Epilepsy, childhood absence, susceptibility to, 5 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001560496 | SCV001782922 | likely benign | not provided | 2018-07-17 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24999380, 24865167) |
Ambry Genetics | RCV002343320 | SCV002647439 | benign | Inborn genetic diseases | 2019-05-03 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003937948 | SCV004749525 | likely benign | GABRB3-related disorder | 2019-06-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |